What is happening in our universe.
BSIM has been awarded two IP vouchers from the “Ideas Powered for business SME Fund”
BSIM Therapeutics announces selection of candidate compound for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
BSIM Therapeutics is awarded a second US Patent
BSIM at the "3rd European ATTR Amyloidosis meeting for Patients and Doctors"
Trademark "BSIM Therapeutics" registered in the US
BSIM Therapeutics is awarded a European Patent
BSIM attended the XVIIth International Symposium on Amyloidosis
BSIM at J.P. Morgan week
The 6th edition of The Meeting of Young Researchers in Computational Structural Biology (EJIBCE), sponsored by BSIM Therapeutics, took place at the Faculty of Sciences, University of Lisbon, on December 20, 2019.
By continuing to browse the site, you expressly agree that cookies will be stored on your computer to help measure statistics of visits and improve the quality of the contents offered.Learn more